This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mirtallo, J. M. Articles by Ruberg, R. L. Search for Related Content PubMed PubMed Citation Articles by Mirtallo, J. M. Articles by Ruberg, R. L. Social Bookmarking                         What's this?

Albumin in TPN Solutions: Potential Savings from a Prospective Review

From the Department of Pharmacy and Division of Pharmacy Practice, the College of Pharmacy, and the College of Medicine of The Ohio State University, Columbus, Ohio

Philip J. Schneider, M.S., R.PH.

From the Department of Pharmacy and Division of Pharmacy Practice, the College of Pharmacy, and the College of Medicine of The Ohio State University, Columbus, Ohio

Robert L. Ruberg, M.D

From the Department of Pharmacy and Division of Pharmacy Practice, the College of Pharmacy, and the College of Medicine of The Ohio State University, Columbus, Ohio

ABSTRACT. As a result of the common usage of albumin in total parenteral nutrition (TPN) solutions at The Ohio State University Hospitals, a review of the use of this product was performed. Albumin therapy in 18 patients was evaluated using prospective criteria. Therapy was considered appropriate if the serum albumin level was less than or equal to 3.0 g%. Using these criteria, 12 of 18 patients (67%) received albumin in the TPN solution. Of these 12 patients, 7 received albumin unnecessarily. During the 3-week review, a total of 168 vials of 50 ml, 25% albumin (2100 g) were administered to patients with serum albumin concentrations greater than 3.0 g/100 ml at a cost of $6,014. Over a year, this could mean over $100,000 in costs which could be eliminated. Criteria for use of albumin in malnourished patients receiving TPN are not well established. This study demonstrated that developing simple criteria for the prospective review of albumin in TPN solutions and using them to monitor albumin therapy closely, can result in very significant cost savings to patients receiving TPN.

Journal of Parenteral and Enteral Nutrition, Vol. 4, No. 3, 300-302 (1980)
DOI: 10.1177/014860718000400311


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. R. Lester, C. M. Crill, and E. B. Hak Should adding albumin to parenteral nutrient solutions be considered an unsafe practice? Am. J. Health Syst. Pharm., September 1, 2006; 63(17): 1656 - 1661. [Abstract] [Full Text] [PDF]

				J. P. Doweiko and D. J. Nompleggi Reviews: The Role of Albumin in Human Physiology and Pathophysiology, Part III: Albumin and Disease States JPEN J Parenter Enteral Nutr, July 1, 1991; 15(4): 476 - 483. [PDF]

				J. P. Doweiko and D. J. Nompleggi Reviews: Role of Albumin in Human Physiology and Pathophysiology JPEN J Parenter Enteral Nutr, March 1, 1991; 15(2): 207 - 211. [Abstract] [PDF]

				J. M. Mirtallo, C. R. Powell, S. M. Campbell, P. J. Schneider, and K. A. Kudsk Invited Review: Cost-Effective Nutrition Support Nutr Clin Pract, August 1, 1987; 2(4): 142 - 151. [PDF]

				D. J. Scheckelhoff, J. M. Mirtallo, R. C. Lisitano, and D. W. Grauer Targeting Specialty Services as an Area for Drg Cost Reduction Strategies: Total Parenteral Nutrition Nutr Clin Pract, June 1, 1987; 2(3): 117 - 122. [PDF]